2024-11-08 - Analysis Report
## Intuitive Surgical Inc (ISRG) Analysis Report

**Company Overview:** Intuitive Surgical Inc. is a medical device company that develops and manufactures robotic surgical systems, instruments, and accessories.

**1. Performance Analysis:**

* **ISRG's cumulative return is 371.43% vs. S&P 500's (VOO) 139.88%.** This shows a significant outperformance by ISRG, with a **231.55%** difference.  
* **Relative divergence:**  This indicates that ISRG's performance is currently at the 79.86th percentile compared to its historical performance relative to VOO, implying strong outperformance in recent times.
* **Alpha & Beta Analysis:**
    * **High Alpha:**  Consistent positive alpha across all periods, indicating strong stock-specific performance.
    * **Beta Close to 1:**  Stable beta around 1, suggesting ISRG tracks the market closely but with slightly higher volatility.
* **Overall:**  ISRG has historically outperformed the market significantly and continues to demonstrate strong performance with positive alpha and a stable beta. 

**2. Recent Price Action:**

* **Closing Price:** $515.55 (Last Market: $524.0)
* **Moving Averages:**
    * 5-day: $509.66
    * 20-day: $503.36
    * 60-day: $490.43
* **Analysis:**  ISRG has recently experienced some price volatility, as it currently trades above its 5-day, 20-day, and 60-day moving averages. The current price is slightly below the last market price, suggesting potential short-term downward pressure.

**3. Technical Indicators:**

* **RSI (73.95):**  Suggests the stock is in overbought territory, potentially indicating a pullback in the short-term.
* **PPO (0):**  Indicates a neutral market sentiment, neither bullish nor bearish.
* **Delta_Previous_Relative_Divergence (4.3):**  Shows a positive divergence over the past 20 days, suggesting short-term bullish momentum.
* **Expected Return (12.59%):**  Indicates a potential long-term (2+ years) outperformance compared to the S&P 500, assuming continued strong performance.

**4. Recent Earnings and Outlook:**

| Date       | EPS      | Revenue     |
|------------|----------|-------------|
| 2024-10-18 | 1.59      | 2.04 B$      |
| 2024-07-19 | 1.48      | 2.01 B$      |
| 2024-04-19 | 1.54      | 1.89 B$      |
| 2023-10-20 | 1.18      | 1.74 B$      |
| 2024-10-18 | 1.18      | 1.74 B$      |

* **Latest Earnings:**  ISRG exceeded analysts' expectations with a strong Q3 2024 EPS of $1.59.
* **Trend:**  Revenue growth is consistently strong, with increasing EPS indicating positive profitability.

**5. Financial Information:**

**1) Revenue and Profitability:**

| Quarter        | Revenue    | Profit Margin |
|----------------|------------|---------------|
| 2024-09-30    | $2.04B     | 67.41%        |
| 2024-06-30    | $2.01B     | 68.30%        |
| 2024-03-31    | $1.89B     | 65.87%        |
| 2023-12-31    | $1.93B     | 66.24%        |
| 2023-09-30    | $1.74B     | 66.94%        |

**2) Capital and Profitability:**

| Quarter        | Equity    | ROE       |
|----------------|------------|------------|
| 2024-09-30    | $15.58B   | 3.63%      |
| 2024-06-30    | $14.71B   | 3.58%      |
| 2024-03-31    | $13.96B   | 3.90%      |
| 2023-12-31    | $13.31B   | 4.56%      |
| 2023-09-30    | $12.54B   | 3.32%      |

* **Analysis:** Strong and consistent revenue growth with high profitability margins. ROE is healthy, indicating efficient use of capital.

**6. News and Recent Issues:**

* **Recent Earnings Report:**  ISRG's recent earnings report received positive feedback from analysts, highlighting strong revenue growth and earnings exceeding expectations. (ShackleNews)
* **Market Outlook:**  Analysts remain optimistic about ISRG's long-term growth potential driven by increasing adoption of robotic surgical systems. (Finbold)
* **Analyst Opinions:**  Most analysts have a "Buy" or "Strong Buy" rating for ISRG, with a price target above the current market price. (Finbold)

**7. Overall Analysis:**

ISRG continues to be a strong performer, demonstrating consistent outperformance compared to the S&P 500. Strong earnings, revenue growth, and profitability indicate healthy fundamentals. Technical indicators suggest potential short-term pullback, but long-term outlook remains positive with high expected return. 

**8. Conclusion:**

ISRG presents a compelling investment opportunity for investors seeking strong growth potential. While short-term price volatility is expected, the company's robust fundamentals, positive technical signals, and positive analyst sentiment suggest continued long-term outperformance. However, investors should consider the potential for short-term pullback and manage their risk accordingly. 
